作者: 平靜生活 時間: 2025-3-21 21:45
第159698主題貼--第2樓 (沙發(fā))作者: Clumsy 時間: 2025-3-22 04:10
板凳作者: 正常 時間: 2025-3-22 06:21
第4樓作者: laparoscopy 時間: 2025-3-22 11:24
5樓作者: Duodenitis 時間: 2025-3-22 14:03
6樓作者: Osteoporosis 時間: 2025-3-22 18:10
7樓作者: 大方不好 時間: 2025-3-22 23:04
8樓作者: myalgia 時間: 2025-3-23 03:29
9樓作者: 適宜 時間: 2025-3-23 07:57
10樓作者: 匯總 時間: 2025-3-23 11:55
第4樓作者: CHOP 時間: 2025-3-23 17:48
第4樓作者: Canyon 時間: 2025-3-23 21:44
5樓作者: 異端邪說2 時間: 2025-3-23 22:21
5樓作者: 迫擊炮 時間: 2025-3-24 02:47
5樓作者: ethereal 時間: 2025-3-24 09:20
5樓作者: 外形 時間: 2025-3-24 14:39
6樓作者: 專心 時間: 2025-3-24 17:12
6樓作者: 博愛家 時間: 2025-3-24 21:21
6樓作者: 產(chǎn)生 時間: 2025-3-25 02:34
6樓作者: affect 時間: 2025-3-25 04:49
7樓作者: Legend 時間: 2025-3-25 10:22
7樓作者: OMIT 時間: 2025-3-25 12:09
7樓作者: integral 時間: 2025-3-25 16:35
7樓作者: N斯巴達人 時間: 2025-3-25 21:35
8樓作者: 燦爛 時間: 2025-3-26 03:25
8樓作者: 包裹 時間: 2025-3-26 07:28 作者: COMMA 時間: 2025-3-26 10:50 作者: APRON 時間: 2025-3-26 15:31
Cyclic AMP Phosphodiesterase-4 in Brain Tumor Biology: Immunochemical AnalysisPDE actions in brain tumor biology, we rigorously examined the patterns of PDE isoform expression. In the following chapter we focus on the PDE4 sub-family of cAMP specific hydrolases and discuss several challenges that arise when examining their patterns of expression by western blotting, immuno-histochemistry and immuno-fluorescence.作者: interference 時間: 2025-3-26 20:46 作者: ATRIA 時間: 2025-3-26 23:43
R. Paul Youngn the first years MCUG was performed 3 and 12 months after endoscopic treatment; after 1999 a single MCUG was performed 3–6 months postoperatively. Minimum follow-up was 6 months.After one injection the overall success rate was 79% of ureters, and 91%, 78%, and 62% for grades II, III, and IV-V VUR, 作者: Microgram 時間: 2025-3-27 02:00 作者: Expand 時間: 2025-3-27 05:20
Cellular and Molecular Mechanisms of Repurposed Antidiabetic Drug as an Adjunctive Treatment for Tuberculosis,ergistic role of metformin with other antitubercular medications have been thoroughly debated. Novel strategy to fight drug-resistant TB in concurrence with future perspectives has been discussed in this chapter.作者: conduct 時間: 2025-3-27 12:06 作者: NIP 時間: 2025-3-27 16:40 作者: 健壯 時間: 2025-3-27 21:00
